Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Annovis Bio (ANVS).
Annovis Bio, Inc. has announced positive results for its leading Alzheimer’s drug, Buntanetap, demonstrating significant efficacy and safety in patients regardless of their genetic risk from Apolipoprotein E4. Following the announcement, the company detailed the drug’s prospects and future plans in a post-market webcast.
See more insights into ANVS stock on TipRanks’ Stock Analysis page.